{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:51:17Z","timestamp":1771059077003,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Geisinger Medical Center"}],"content-domain":{"domain":["jvascsurg.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jvs.2018.12.037","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T02:11:42Z","timestamp":1560996702000},"page":"274-284.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A systematic review and meta-analysis of bivalirudin application in peripheral endovascular procedures"],"prefix":"10.1016","volume":"70","author":[{"given":"Yirui","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia Yian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianren","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Elmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2018.12.037_bib1","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1053\/j.jvca.2017.05.024","article-title":"Incidence and outcomes of heparin-induced thrombocytopenia in patients undergoing vascular surgery","volume":"31","author":"Chaudhry","year":"2017","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jvs.2018.12.037_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1067\/mcp.2002.124522","article-title":"Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and gender","volume":"71","author":"Robson","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jvs.2018.12.037_bib3","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1248\/bpb.34.1841","article-title":"Pharmacokinetics, pharmacodynamics, tolerability and safety of single doses of bivalirudin in healthy Chinese subjects","volume":"34","author":"Zhang","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jvs.2018.12.037_bib4","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/01.CIR.87.5.1622","article-title":"Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty","volume":"87","author":"Topol","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.12.037_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jcin.2010.10.011","article-title":"Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention","volume":"4","author":"Verheugt","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2018.12.037_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/ccd.26146","article-title":"Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: a patient-level pooled analysis from three randomized trials","volume":"87","author":"Yu","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2018.12.037_bib7","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(09)61484-7","article-title":"Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial","volume":"374","author":"Mehran","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2018.12.037_bib8","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.12.037_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0741-5214(96)70191-X","article-title":"Results of peripheral endovascular procedures in the operating room","volume":"24","author":"Gross","year":"1996","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.12.037_bib10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0002-9610(99)80279-7","article-title":"Incorporation of endovascular training into a vascular fellowship program","volume":"170","author":"Hodgson","year":"1995","journal-title":"Am J Surg"},{"key":"10.1016\/j.jvs.2018.12.037_bib11","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jvs.2006.01.023","article-title":"Current guidelines produce competent endovascular surgeons","volume":"43","author":"Weaver","year":"2006","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.12.037_bib12","first-page":"651","article-title":"The Angiomax Peripheral Procedure Registry of Vascular Events Trial (APPROVE): in-hospital and 30-day results","volume":"16","author":"Allie","year":"2004","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jvs.2018.12.037_bib13","series-title":"Cochrane handbook for systematic reviews of interventions 5.1.0","first-page":"33","author":"Higgins","year":"2011"},{"key":"10.1016\/j.jvs.2018.12.037_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jvs.2018.12.037_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7326\/0003-4819-115-4-256","article-title":"Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial","volume":"115","author":"Bovill","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jvs.2018.12.037_bib16","series-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2009"},{"key":"10.1016\/j.jvs.2018.12.037_bib17","first-page":"40","article-title":"Meta: an R package for meta-analysis","volume":"7","author":"Schwarzer","year":"2007","journal-title":"R\u00a0News"},{"key":"10.1016\/j.jvs.2018.12.037_bib18","first-page":"334","article-title":"Bivalirudin as a foundation anticoagulant in peripheral vascular disease: a safe and feasible alternative for renal and iliac interventions","volume":"15","author":"Allie","year":"2003","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jvs.2018.12.037_bib19","first-page":"427","article-title":"A\u00a0safety and feasibility report of combined direct thrombin and GP IIb\/IIIa inhibition with bivalirudin and tirofiban in peripheral vascular disease intervention: treating critical limb ischemia like acute coronary syndrome","volume":"17","author":"Allie","year":"2005","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.jvs.2018.12.037_bib20","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s00270-007-9038-1","article-title":"Similar success rates with bivalirudin and unfractionated heparin in bare-metal stent implantation","volume":"30","author":"Hallak","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2018.12.037_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jvir.2008.09.031","article-title":"Clinical experience with the use of bivalirudin in a large population undergoing endovascular abdominal aortic aneurysm repair","volume":"20","author":"Stamler","year":"2009","journal-title":"J\u00a0Vasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2018.12.037_bib22","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jcin.2009.06.015","article-title":"Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in percutaneous peripheral intervention: a single-center experience","volume":"2","author":"Sheikh","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2018.12.037_bib23","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jvs.2010.06.098","article-title":"Heparin versus bivalirudin for carotid artery stenting using proximal endovascular clamping for neuroprotection: results from a prospective randomized study","volume":"52","author":"Stabile","year":"2010","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.12.037_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1583\/09-2810.1","article-title":"In-hospital safety and effectiveness of bivalirudin in percutaneous peripheral interventions: data from a real-world registry","volume":"17","author":"Shammas","year":"2010","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2018.12.037_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12028-010-9421-7","article-title":"Safety and tolerability of high-intensity anticoagulation with bivalirudin during neuroendovascular procedures","volume":"15","author":"Hassan","year":"2011","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.jvs.2018.12.037_bib26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1540-8183.2011.00684.x","article-title":"Bivalirudin used as alternative anticoagulant in carotid artery stenting: a single center observational study","volume":"25","author":"Geisbusch","year":"2012","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.jvs.2018.12.037_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCINTERVENTIONS.112.974857","article-title":"Hemorrhagic and ischemic outcomes after bivalirudin versus unfractionated heparin during carotid artery stenting: a propensity score analysis from the NCDR","volume":"6","author":"Wayangankar","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2018.12.037_bib28","doi-asserted-by":"crossref","first-page":"e002823","DOI":"10.1161\/CIRCINTERVENTIONS.115.002823","article-title":"Bivalirudin is associated with improved in-hospital outcomes compared with heparin in percutaneous vascular interventions: observational, propensity-matched analysis from the Premier Hospital Database","volume":"9","author":"Kimmelstiel","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2018.12.037_bib30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ccd.26684","article-title":"Bivalirudin versus unfractionated heparin during peripheral vascular interventions: a propensity-matched study","volume":"89","author":"Ortiz","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2018.12.037_bib31","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1311096","article-title":"Bivalirudin started during emergency transport for primary PCI","volume":"369","author":"Steg","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.12.037_bib32","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.amjcard.2004.01.033","article-title":"Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)","volume":"93","author":"Lincoff","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvs.2018.12.037_bib33","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2007.02.027","article-title":"Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial","volume":"49","author":"Manoukian","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2018.12.037_bib34","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jama.292.6.696","article-title":"Long-term efficacy of bivalirudin and provisional glycoprotein IIb\/IIIa blockade vs heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. [Erratum appears in JAMA 2006;296:46]","volume":"292","author":"Lincoff","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2018.12.037_bib35","first-page":"1792","article-title":"Economic evaluation of bivalirudin with provisional glycoprotein IIB\/IIIA inhibition versus heparin with routine glycoprotein IIB\/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial","volume":"44","author":"Cohen","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2018.12.037_bib36","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.jacc.2008.08.021","article-title":"Economic evaluation of bivalirudin with or without glycoprotein IIb\/IIIa inhibition versus heparin with routine glycoprotein IIb\/IIIa inhibition for early invasive management of acute coronary syndromes","volume":"52","author":"Pinto","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14 Suppl 3","key":"10.1016\/j.jvs.2018.12.037_bib37","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/ajhp\/60.suppl_3.S15","article-title":"Economic impact of bleeding complications and the role of antithrombotic therapies in percutaneous coronary intervention","volume":"60","author":"Milkovich","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jvs.2018.12.037_bib38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehp437","article-title":"Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention","volume":"31","author":"Rassen","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2018.12.037_bib39","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/ccd.26685","article-title":"Hemorrhagic and ischemic outcomes of heparin vs. bivalirudin in carotid artery stenting: a meta-analysis of studies","volume":"89","author":"Omran","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2018.12.037_bib40","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(11)60764-2","article-title":"Heparin plus a glycoprotein IIb\/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial","volume":"377","author":"Stone","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2018.12.037_bib41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.thromres.2005.07.020","article-title":"Increased expression of platelet P-selectin and formation of platelet-leukocyte aggregates in blood from patients treated with unfractionated heparin plus eptifibatide compared with bivalirudin","volume":"118","author":"Keating","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvs.2018.12.037_bib42","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1160\/TH08-09-0582","article-title":"Bivalirudin reduces platelet and monocyte activation after elective percutaneous coronary intervention","volume":"101","author":"Busch","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvs.2018.12.037_bib43","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1161\/ATVBAHA.107.144576","article-title":"Effects of unfractionated heparin and glycoprotein IIb\/IIIa antagonists versus bivalirudin on myeloperoxidase release from neutrophils","volume":"27","author":"Li","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvs.2018.12.037_bib44","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1124\/jpet.108.142414","article-title":"Bivalirudin decreases NO bioavailability by vascular immobilization of myeloperoxidase","volume":"327","author":"Rudolph","year":"2008","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jvs.2018.12.037_bib45","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa035003","article-title":"Prognostic value of myeloperoxidase in patients with chest pain","volume":"349","author":"Brennan","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2018.12.037_bib46","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.thromres.2015.06.001","article-title":"Risk of stent thrombosis and major bleeding with bivalirudin compared with active control: a systematic review and meta-analysis of randomized trials","volume":"136","author":"Kianoush","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvs.2018.12.037_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/joic.12280","article-title":"Post-procedural bivalirudin infusion following primary PCI to reduce stent thrombosis","volume":"29","author":"Kinnaird","year":"2016","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.jvs.2018.12.037_bib48","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ijcard.2016.06.247","article-title":"Potential mechanism of acute stent thrombosis with bivalirudin following percutaneous coronary intervention in acute coronary syndromes","volume":"220","author":"Laine","year":"2016","journal-title":"Int J Cardiol"}],"updated-by":[{"DOI":"10.1016\/j.jvs.2019.06.104","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000}}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521419301818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521419301818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T02:35:06Z","timestamp":1560998106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521419301818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0741521419301818"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2018.12.037","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jvs.2019.06.104","asserted-by":"object"}]},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review and meta-analysis of bivalirudin application in peripheral endovascular procedures","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2018.12.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}